Skip to content

Clinical comprehensive evaluation of Chinese patent medicine "Zishen Yutong pill" in the treatment of threatened abortion

Clinical comprehensive evaluation of Chinese patent medicine "Zishen Yutong pill" in the treatment of threatened abortion

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400081251
Enrollment
Unknown
Registered
2024-02-27
Start date
2024-03-01
Completion date
Unknown
Last updated
2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Threatened abortion

Interventions

Experimental group:Patients with threatened abortion treated with basic therapeutic drugs combined with Zishenyutong pill(YNMT)·

Sponsors

Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: (1) 18 years = age =45 years, gestational age =28 weeks; (2) Meet the criteria for threatened abortion.

Exclusion criteria

Exclusion criteria: (1) those diagnosed as having aborted embryos by examination; (2) Threatened abortion caused by cervical laxity, genetic diseases, reproductive tract infections, abnormal uterine or fetal development, and chromosomal abnormalities; (3) combined with other serious systemic diseases; (4) Persons with disabilities defined by law (blind, deaf, mute, mentally handicapped, mentally handicapped, physically handicapped) and mentally ill persons; (5) Participate in other clinical trials within 3 months before screening. (6) Suspected or confirmed alcohol or drug abuse; (7) known allergy to the components of this group of drugs; (8) Those deemed inappropriate by the researcher.

Design outcomes

Primary

MeasureTime frame
Abortion rate;Success rate of fetal protection;

Secondary

MeasureTime frame
Total length of hospital stay;

Countries

China

Contacts

Public ContactWuJunyan

Sun Yat-sen Memorial Hospital, Sun Yat-sen University

13926018606@139.com+86 20 8133 2451

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026